Organon announced that CEO Kevin Ali intends to resign from his position following results from an internal investigation ...

GSK is set to acquire the exclusive rights for Syndivia’s preclinical antibody-drug conjugate (ADC), which is currently in ...

Novartis will acquire Avidity Biosciences in a newly announced definitive merger agreement. The news follows the separation ...

Obesity is a complex, treatable medical condition, not just a matter of willpower, requiring a shift in perception and ...

Biologic age is determined by measuring how well the body’s cells and organs are functioning. This is different than ...

PE: What makes TrumpRx different from other government-run health programs? O’Dell: TrumpRx is different in that its ...

In today’s Pharmaceutical Executive Daily, we cover the FDA approval of Bayer’s Lynkuet for menopausal hot flashes, new research suggesting Ozempic may reduce biological age, and Novartis’ $12 billion ...

Eli Lilly and Company announced a definitive agreement to acquire Aderum Biotechnologies and its leading candidate Ixo-vec. 1 ...

Moderna announced its decision to cease development of its vaccine mRNA-1647, which was being designed to treat birth defects ...

In today’s Pharmaceutical Executive Daily, we cover market reaction to Novo Nordisk’s recent board shake-up, MJH Life ...

Innovent Biologics and Takeda announced a strategic global collaboration aiming to advance next-generation IO and ADC cancer ...

AI transforms pharmaceutical operations by automating workflows, ensuring transparency, and enhancing compliance, driving ...